Biop Medical

Early and Accurate Detection of Cervical Cancer

Health Tech & Life Sciences
Non Active, Oct 2025 ceased to operate

Company Overview

Snapshot

Founded in December 2012, Biop Medical operates with 1–10 employees and has raised a total of $4.45 million across three funding rounds. In December 2018, the company received FDA approval for its cervical cancer detection technology.

Business overview

Biop Medical develops technology for the early and accurate detection of cancerous and precancerous cells in epithelial tissue, specifically focusing on cervical cancer. The company's core product is a micro-colposcope probe that utilizes optical phenomena and optomechanical designs to generate a real-time map of the entire cervix. This technology aims to make colposcopies faster, more comfortable, and more accurate by using an advanced algorithm to indicate and determine the exact location of injured or infected areas. Biop Medical serves the healthcare industry, targeting gynecologists and healthcare providers, and operates within the Health Tech & Life Sciences sector, specializing in Medical Devices and Diagnostics Devices.

Strategic signal

In December 2018, Biop Medical secured FDA approval for its cervical cancer detection technology. This regulatory milestone is a significant validation of the company's device, signaling its readiness for broader market adoption and potential to transform point-of-care diagnosis in gynecology. For investors, this approval indicates a de-risked pathway to commercialization and market entry in the critical US healthcare market.

Company Intelligence Q&A

What is Biop Medical's primary focus?
Biop Medical focuses on developing technology for the early and accurate detection of cancerous and precancerous cells in epithelial tissue, specifically for cervical cancer.
When did Biop Medical receive FDA approval for its technology?
In December 2018, Biop Medical received FDA approval for its cervical cancer detection technology.
Which company participated in Biop Medical's April 2016 funding round?
In April 2016, Shanghai Creative Investments participated in a funding round for Biop Medical.
Which organization provided a grant to Biop Medical in November 2016?
In November 2016, Biop Medical received a grant from the Israel Innovation Authority.
What is the status of Biop Medical as of October 2025?
As of October 2025, Biop Medical ceased to operate and is listed as Non Active.

External links